Hong, Cheng William http://orcid.org/0000-0002-5219-6039
Marsh, Austin
Wolfson, Tanya
Paige, Jeremy
Dekhordy, Soudabeh Fazeli
Schlein, Alexandra N.
Housman, Elise
Deiranieh, Lisa H.
Li, Charles Q.
Wasnik, Ashish P.
Jang, Hyun-Jung
Dietrich, Christoph F.
Piscaglia, Fabio
Casola, Giovanna
O’Boyle, Mary
Richman, Katherine M.
Valasek, Mark A.
Andre, Michael
Loomba, Rohit
Sirlin, Claude B. http://orcid.org/0000-0002-6639-9072
Funding for this research was provided by:
National Institute of Biomedical Imaging and Bioengineering (T32 EB005970-09)
National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK106419-03)
Article History
First Online: 28 June 2018
Compliance with ethical standards
:
: The authors acknowledge Grant support from the National Institutes of Health T32 EB005970-09 and R01 DK106419-03. The study was also supported in part by an investigator-initiated research grant from Siemens to the senior and second senior author. No author of this study is an employee or consultant to Siemens. All data belonged to the authors who had complete control of the manuscript content. The senior author has research grants from Siemens, GE, Philips, and Bayer.
: C.W.H., A.W., T.W., J.P., S.F.D., A.S.N., E.H., L.D., C.Q.L., A.W, H.J.J., C.F.D., G.C., M.O.B., K.M.R., M.A.V., and M.A. declare that they have no conflicts of interest. F.P. is on the advisory board and speaker bureau of Bayer, on the advisory board of EISAI, on the speaker bureau of Bracco, and has a research contract with ESAOTE. R.L. receives grant funding from Adheron, Arora, BMS, Daiichi-Sankyo Inc., Galectin, Galmed, GE, Genfit, Gilead, Immuron, Intercept, Janssen Inc, KineMed, Madrigal, Merck, NGM, Promedior, Prometheus, Siemens, Sirius, and Tobira and is a consultant or on the advisory committee for Bird Rock Bio, BMS, Boehringer Ingelheim, Celgene, Conatus, Eli Lily, Enanta, Gilead, GRI Bio, Madrigal, Metacrine, NGM, Pfizer, Receptos, Sanofi, Scholar Rock, Zafgen, Arrowhead Research, Conatus, Galmed, Gilead, Intercept, NGM, Nimbus, Octeta, Tobira, GIR, Inc., and Metacrine, Inc. C.S. receives grant funding from Gilead, GE Healthcare, Siemens, GE MRI, Bayer AMRI, GE Digital, GE US, ACR Innovation, performs contracted research for ICON Medical Imaging/Enanta, Philips, Gilead, Shire, VirtualScopics, Intercept, Synageva, is a consultant for Boehringer Ingelheim, is a member of the external advisory board of AMRA Medical and Guerbet (fee paid to the University of California Regents), and a speaker for GE Healthcare and Bayer (fee paid to the University of California Regents).
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.